Free Trial

Cigna Group $CI Shares Purchased by CW Advisors LLC

Cigna Group logo with Medical background

Key Points

  • CW Advisors LLC increased its stake in Cigna Group by 7.9%, owning 21,140 shares valued at approximately $6.95 million as of the last SEC filing.
  • Several large investors have recently bought shares, with 86.99% of Cigna's stock owned by hedge funds and institutional investors, while insider Nicole S. Jones sold over 28,000 shares, decreasing her stake by 52.66%.
  • Analysts have revised target prices for Cigna Group, with Barclays lowering it to $354.00, while Truist Financial set a target at $405.00, indicating mixed ratings among research firms.
  • Looking to export and analyze Cigna Group data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

CW Advisors LLC increased its stake in shares of Cigna Group (NYSE:CI - Free Report) by 7.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 21,140 shares of the health services provider's stock after purchasing an additional 1,543 shares during the quarter. CW Advisors LLC's holdings in Cigna Group were worth $6,951,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Evermay Wealth Management LLC lifted its holdings in Cigna Group by 58.6% in the first quarter. Evermay Wealth Management LLC now owns 111 shares of the health services provider's stock valued at $37,000 after acquiring an additional 41 shares during the period. Richardson Financial Services Inc. acquired a new stake in Cigna Group in the first quarter valued at $38,000. Wayfinding Financial LLC acquired a new stake in Cigna Group in the first quarter valued at $40,000. Putney Financial Group LLC acquired a new stake in Cigna Group in the fourth quarter valued at $36,000. Finally, Ameriflex Group Inc. acquired a new stake in Cigna Group in the fourth quarter valued at $44,000. Hedge funds and other institutional investors own 86.99% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Barclays reduced their target price on Cigna Group from $385.00 to $354.00 and set an "overweight" rating for the company in a report on Friday, August 1st. Wall Street Zen downgraded Cigna Group from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Wells Fargo & Company reduced their target price on Cigna Group from $341.00 to $340.00 and set an "equal weight" rating for the company in a report on Thursday, August 14th. Guggenheim reaffirmed a "buy" rating and set a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Finally, Truist Financial lifted their price target on Cigna Group from $385.00 to $405.00 and gave the stock a "buy" rating in a research note on Monday, May 12th. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, Cigna Group has an average rating of "Buy" and an average target price of $374.82.

Read Our Latest Research Report on Cigna Group

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.70% of the company's stock.

Cigna Group Trading Up 1.1%

Cigna Group stock opened at $304.1390 on Friday. The stock has a market cap of $81.18 billion, a PE ratio of 16.60, a P/E/G ratio of 0.88 and a beta of 0.47. The stock has a 50-day moving average price of $300.91 and a 200 day moving average price of $311.39. Cigna Group has a 52 week low of $256.89 and a 52 week high of $370.83. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts' consensus estimates of $7.15 by $0.05. The firm had revenue of $67.13 billion during the quarter, compared to analysts' expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm's quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the business posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Thursday, September 4th will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date is Thursday, September 4th. Cigna Group's dividend payout ratio (DPR) is currently 32.97%.

About Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Read More

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market
Next Tech Boom: AI Robots Are Coming Sooner Than You Think!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines